Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02079701 · ClinicalTrials.gov registry record · Phase 4
Effectiveness of the Pneumococcal Polysaccharide Vaccine in Military Recruits
A Phase 4 study, sponsored by Naval Health Research Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 152,723
- Enrollment target
NCT02079701 is a Phase 4 study that has completed, run by Naval Health Research Center. The registered enrollment target is 152,723 participants.
The verdict
NCT02079701, a Phase 4 study, has completed, sponsored by Naval Health Research Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 152,723 participants
- Enrollment target
Study Summary
The primary objective is to determine the clinical benefit of employing the 23-valent pneumococcal vaccine among US military trainees. Secondary objectives include: * determining the etiology of clinical pneumonia among U.S. military trainees; * comparing the serotype distribution of S. pneumoniae (Sp) isolates recovered from vaccinated and nonvaccinated trainees diagnosed with pneumonia; and * comparing days lost from training due to pneumonia or acute respiratory disease for vaccinated and nonvaccinated subjects.
Interventions
- BIOLOGICAL Placebo
- BIOLOGICAL 23-valent pneumococcal vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152,723 participants |
| Start Date | 2000-10 |
| Est. Completion | 2007-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02079701
The ClinicalTrials.gov registry entry for NCT02079701 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 152,723 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Naval Health Research Center, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02079701 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02079701 about?
NCT02079701 is a clinical study titled "Effectiveness of the Pneumococcal Polysaccharide Vaccine in Military Recruits". The primary objective is to determine the clinical benefit of employing the 23-valent pneumococcal vaccine among US military trainees. Secondary objectives include: * determining the etiology of clinical pneumonia among U.S. military trainees; * comparing the serotype distribution of S. pneumoniae ...
What is the current status of trial NCT02079701?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 152,723 participants. The study started on 2000-10. Estimated completion is 2007-06.
What interventions are being tested in trial NCT02079701?
The interventions under investigation include: Placebo (BIOLOGICAL), 23-valent pneumococcal vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT02079701?
This trial is sponsored by Naval Health Research Center, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.